Back to Search
Start Over
Characterization of loss-of-inactive X in Klinefelter syndrome and female-derived cancer cells.
- Source :
- Oncogene; 8/12/2004, Vol. 23 Issue 36, p6163-6169, 7p
- Publication Year :
- 2004
-
Abstract
- The increased risk of several types of cancer in Klinefelter syndrome (47XXY) suggests that the extra X chromosome may be involved in the tumorigenesis associated with this syndrome. Here, we show that cancer cells (PSK-1) derived from a patient with Klinefelter syndrome (47XXY) showing loss of an inactive X chromosome subsequently gained active X chromosomes. We found that this abnormal X chromosome composition in PSK-1 is caused by a loss of an inactive X chromosome followed by multiplication of identical active X chromosomes, not by reactivation of an inactive X chromosome. Furthermore, we extended the characterization of loss-of-inactive X in a series of 22 female-derived cancer cell lines (eight breast cancer cell lines, seven ovarian cancer cell lines, and seven cervical cancer cell lines). The data demonstrate that loss-of-inactive X in the female-derived cancer cells is mainly achieved by loss of an inactive X chromosomes followed by multiplication of an identical active X chromosomes. However, distinctive pathways, including reactivation of an inactive X chromosome, are also involved in the mechanisms for loss-of-inactive X and gain-of-active X in female-derived cancer cells. The biological significance of the loss-of-inactive X and gain-of-active X in the oncogenesis of Klinefelter syndrome and female-derived cancer cells are discussed.Oncogene (2004) 23, 6163-6169. doi:10.1038/sj.onc.1207808 Published online 14 June 2004 [ABSTRACT FROM AUTHOR]
- Subjects :
- CELLS
CANCER patients
SEX chromosomes
GENETICS
DISEASES
CHROMOSOMES
Subjects
Details
- Language :
- English
- ISSN :
- 09509232
- Volume :
- 23
- Issue :
- 36
- Database :
- Complementary Index
- Journal :
- Oncogene
- Publication Type :
- Academic Journal
- Accession number :
- 14097072
- Full Text :
- https://doi.org/10.1038/sj.onc.1207808